Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2010

01-05-2010 | Poster presentation

Assessing the functional role of caspase-8 gene variants in breast cancer

Authors: SH Rigas, M Parry, MW Reed, N Camp, A Cox

Published in: Breast Cancer Research | Special Issue 1/2010

Login to get access

Excerpt

Mutations in high-penetrance genes such as BRCA1 and BRCA2 predispose to breast cancer, and recently a number of low-penetrance breast cancer genes have also been identified. We reported that a coding SNP in the caspase-8 gene (CASP8 D302H) is associated with a reduced risk of breast cancer. More recently we identified a CASP8 4-SNP haplotype associated with an increased risk of breast cancer [1]. A CASP8 promoter indel has been associated with breast cancer in an Asian population, although this has not been confirmed in Europeans. Our hypothesis is that these CASP8 variants may influence breast cancer susceptibility via effects on the apoptotic response. …
Literature
1.
Metadata
Title
Assessing the functional role of caspase-8 gene variants in breast cancer
Authors
SH Rigas
M Parry
MW Reed
N Camp
A Cox
Publication date
01-05-2010
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2010
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2521

Other articles of this Special Issue 1/2010

Breast Cancer Research 1/2010 Go to the issue

Poster presentation

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

Poster presentation

PLU-1/Jarid1B contributes to estrogen-induced cell proliferation in the normal mammary gland and in breast cancer, and is required for embryonic survival

Poster presentation

Identification of signalling pathways downstream of BRCA1 and p63

Poster presentation

Clinicopathologic and molecular predictors of axillary lymph node metastasis in early-stage breast cancer: a mathematical predictive model

Poster presentation

Lack of correlation between markers of breast cancer initiating cells

Poster presentation

Opticin: a potent anti-angiogenic/antiproliferative agent for breast cancer therapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits